Investors
Investor Information
Revolo Biotherapeutics is a privately held, venture-funded biotechnology firm engaged in the development of unique and revolutionary therapies. Looking to learn more? Don’t hesitate to contact us.
Events
Upcoming Events
There are no upcoming events at this time.
Past Events
19
May
Poster – IRL201104, a Novel Immunomodulatory Peptide, Prevents Inflammatory Infiltration and Proinflammatory Cytokine Release in a New Model of ARDS Associated to Influenza Infection – Washinton, D.C.
20
Apr
April 20th 2023 – 8th Food Allergy Fund Summit
Corporate presentation – New York
27
Feb
February 27th 2023 – 2023 American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
Oral Presentation – IRL201104, A Novel Immunomodulatory Peptide, Shows A Long Lasting Reduction In Anaphylaxis Symptoms And Allergy Biomarkers In A Murine Model Of Food Allergy – San Antonio